Abstract
SummaryBackgroundIn May 2021, the Delta SARS-CoV-2 variant became dominant in the UK. This variant is associated with increased transmissibility compared to the Alpha variant that was previously dominant. To understand ongoing transmission and interventions, a key question is whether the Delta variant generation time (the time between infections in infector- infectee pairs) is typically shorter–i.e., transmissions are happening more quickly–or whether infected individuals simply generate more infections.MethodsWe analysed transmission data from a UK Health Security Agency household study. By fitting a mathematical transmission model to the data, we estimated the generation times for the Alpha and Delta variants.ResultsThe mean intrinsic generation time (the generation time if there had been a constant supply of susceptibles throughout infection) was shorter for the Delta variant (4·6 days, 95% CrI 4·0-5·4 days) than the Alpha variant (5·5 days, 95% CrI 4·6-6·4 days), although within uncertainty ranges. However, there was a larger difference in the realised mean household generation time between the Delta (3·2 days, 95% CrI 2·4-4·2 days) and Alpha (4·5 days, 95% CrI 3·7-5·4 days) variants. This is because higher transmissibility led to faster susceptible depletion in households, in addition to the reduced intrinsic generation time.ConclusionsThe Delta variant transmits more quickly than previously circulating variants. This has implications for interventions such as contact tracing, testing and isolation, which are less effective if the virus is transmitted quickly. Epidemiological models of interventions should be updated to include the shorter generation time of the Delta variant.
Publisher
Cold Spring Harbor Laboratory
Reference32 articles.
1. Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England (Technical briefing 23). 2021.
2. World Health Organization. Weekly epidemiological update on COVID-19 (Edition 58). 2021.
3. Twohig KA , Nyberg T , Zaidi A , et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis 2021.
4. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant;N Engl J Med,2021
5. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021;Eurosurveillance,2021